Vertex Pharmaceuticals (VRTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 481 |
| % of all portfolios: | 0.032% |
| Hold Price * : | $446.52 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
78 |
$118,090,544 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Tweedy Browne |
1.43 |
Add 3.16% |
40,387 |
18,034,000 |
| ≡ |
Torray Funds |
1.08 |
Reduce 0.52% |
15,386 |
6,870,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 07 Aug 2025 |
KEWALRAMANI RESHMA |
CEO & President |
06 Aug 2025 |
5,710 |
389.95 |
2,226,614 |
| 07 Aug 2025 |
KEWALRAMANI RESHMA |
CEO & President |
06 Aug 2025 |
4,290 |
389.08 |
1,669,153 |
| 07 Aug 2025 |
SACHS BRUCE I |
Director |
06 Aug 2025 |
1,634 |
389.36 |
636,214 |
| 07 Aug 2025 |
SACHS BRUCE I |
Director |
06 Aug 2025 |
3,366 |
389.84 |
1,312,201 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock